AGK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.729740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.028000E-02
Normal-vs-Stage2
1.812260E-02
Normal-vs-Stage3
6.187700E-02
Normal-vs-Stage4
1.611560E-01
Stage1-vs-Stage2
8.318400E-01
Stage1-vs-Stage3
1.934960E-01
Stage1-vs-Stage4
7.934800E-01
Stage2-vs-Stage3
1.128560E-01
Stage2-vs-Stage4
6.361000E-01
Stage3-vs-Stage4
5.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.913800E-02
Normal-vs-AfricanAmerican
1.732580E-01
Normal-vs-Asian
1.886260E-02
Caucasian-vs-AfricanAmerican
5.871600E-01
Caucasian-vs-Asian
1.273570E-01
AfricanAmerican-vs-Asian
6.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.412420E-02
Normal-vs-Female
3.062300E-02
Male-vs-Female
4.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.136840E-01
Normal-vs-Age(41-60Yrs)
2.776400E-02
Normal-vs-Age(61-80Yrs)
1.920450E-02
Normal-vs-Age(81-100Yrs)
2.569800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.126200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.861200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.221600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.010130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.122000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.748600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.019500E-02
Normal-vs-Daily Drinker
4.760000E-02
Normal-vs-Weekly Drinker
1.714410E-01
Normal-vs-Occasional Drinker
4.713600E-02
Normal-vs-Social Drinker
1.253600E-01
Non Drinker-vs-Daily Drinker
4.593000E-01
Non Drinker-vs-Weekly Drinker
2.824000E-01
Non Drinker-vs-Occasional Drinker
2.611400E-01
Non Drinker-vs-Social Drinker
1.567760E-02
Daily Drinker-vs-Weekly Drinker
6.448600E-01
Daily Drinker-vs-Occasional Drinker
7.033600E-01
Daily Drinker-vs-Social Drinker
8.808400E-02
Weekly Drinker-vs-Occasional Drinker
8.719000E-01
Weekly Drinker-vs-Social Drinker
3.719800E-01
Occasional Drinker-vs-Social Drinker
1.489820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.621800E-01
Normal-vs-Grade 2
9.059600E-01
Normal-vs-Grade 3
9.160800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.146800E-01
Grade 1-vs-Grade 3
4.400800E-01
Grade 1-vs-Grade 4
9.621800E-01
Grade 2-vs-Grade 3
7.697000E-01
Grade 2-vs-Grade 4
9.059600E-01
Grade 3-vs-Grade 4
9.160800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.999870E-02
Normal-vs-NonDiabetic
2.173800E-02
Diabetic-vs-NonDiabetic
4.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.681560E-01
Normal-vs-NoPancreatitis
1.131690E-02
Pancreatitis-vs-NoPancreatitis
1.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.614400E-02
Normal-vs-N1
1.334180E-02
N0-vs-N1
5.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.740500E-02
Normal-vs-TP53-NonMutant
5.659900E-02
TP53-Mutant-vs-TP53-NonMutant
2.426400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
